For overexpression studies, the following plasmids (600 ng per transfection) were used: pFOXO1-EGFP-N1, pFOXO3-EGFP-N1, pFOXO6-EGFP-N1 and p-EGFP-N1 as empty vector control. pGL4.11-Bmal1::luciferase (200 ng) was used as circadian reporter, pFlag-CLOCK (600 ng) was used to rescue FoxO3 siRNA with pcDNA-Neo as empty vector control. For FoxO3 promoter studies, two plasmids with 1.4 kb and 2.1 kb of the FoxO3 promoter cloned into a pGL3::luciferase vector (see below) were used with pGL3::luciferase as empty vector control. For knockdown studies, siRNA oligos (50 pmol) against FoxO1 (siO1), FoxO3 (siO3), FoxO6 (siO6) or a scrambled siRNA (siC) were used. Transient transfections were performed using Lipofectamine2000 (Invitrogen, Waltham, MA, USA) according to the manufacturer’s instructions unless specified otherwise.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.